Literature DB >> 21323963

The retinoblastoma protein/p16 INK4A pathway but not p53 is disrupted by human papillomavirus in penile squamous cell carcinoma.

Elzbieta Stankiewicz1, David M Prowse, Elena Ktori, Jack Cuzick, Laurence Ambroisine, Xiaoxi Zhang, Sakunthala Kudahetti, Nicholas Watkin, Catherine Corbishley, Daniel M Berney.   

Abstract

AIMS: The pathogenesis of penile squamous cell carcinoma (PSCC) is not well understood. Human papillomavirus (HPV) may be involved in carcinogenesis, but few studies have compared cell-cycle protein expression in HPV positive and negative cancers. The aim was to determine the extent of HPV infection in different histological subtypes of PSCC and its impact on the expression of key cell-cycle proteins: p53, p21, p16(INK4A) and retinoblastoma (RB) protein. METHODS AND
RESULTS: One hundred and forty-eight PSCC samples were examined immunohistochemically for RB, p16(INK4A) , p53 and p21 protein expression. One hundred and two cases were typed for HPV by PCR. HPV DNA was detected in 56% of tumours, with HPV16 present in 81%. Basaloid tumours were related strongly to HPV infection (10 of 13), while verrucous were not (three of 13). Fifty-nine per cent (38 of 64) of usual type SCCs had HPV infection. RB protein correlated negatively (P<0.0001) and p16(INK4A) (P<0.0001) and p21 (P=0.0002) correlated positively with HPV infection. p53 did not correlate with HPV infection.
CONCLUSIONS: HPV infection is present in more than half of penile cancers and it is responsible for RB pathway disruption. However, no link between HPV and p53 immunodetection was found. Only basaloid and half of usual-type PSSCs correlate with HPV infection, confirming possible separate aetiologies for those tumours.
© 2011 Blackwell Publishing Limited.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21323963     DOI: 10.1111/j.1365-2559.2011.03762.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  7 in total

Review 1.  Male genital premalignant dermatoses.

Authors:  Oliver Kayes; Majid Shabbir; Suks Minhas
Journal:  Curr Urol Rep       Date:  2012-12       Impact factor: 3.092

Review 2.  [Pathology and histopathological evaluation of penile cancer].

Authors:  A Erbersdobler
Journal:  Urologe A       Date:  2018-04       Impact factor: 0.639

Review 3.  Penile cancer: current therapy and future directions.

Authors:  G Sonpavde; L C Pagliaro; C Buonerba; T B Dorff; R J Lee; G Di Lorenzo
Journal:  Ann Oncol       Date:  2013-01-04       Impact factor: 32.976

4.  HPV-negative penile squamous cell carcinoma: disruptive mutations in the TP53 gene are common.

Authors:  Karl Kashofer; Elke Winter; Iris Halbwedl; Andrea Thueringer; Marisa Kreiner; Stefan Sauer; Sigrid Regauer
Journal:  Mod Pathol       Date:  2017-04-07       Impact factor: 7.842

5.  The etiologic role of human papillomavirus in penile cancers: a study in Vietnam.

Authors:  H T T Do; C Koriyama; N A Khan; M Higashi; T Kato; N T Le; S Matsushita; T Kanekura; S Akiba
Journal:  Br J Cancer       Date:  2013-01-08       Impact factor: 7.640

6.  Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomas.

Authors:  Elzbieta Stankiewicz; David M Prowse; Mansum Ng; Jack Cuzick; David Mesher; Frances Hiscock; Yong-Jie Lu; Nicholas Watkin; Catherine Corbishley; Wayne Lam; Daniel M Berney
Journal:  PLoS One       Date:  2011-03-02       Impact factor: 3.240

7.  DNA Copy Number Aberrations, and Human Papillomavirus Status in Penile Carcinoma. Clinico-Pathological Correlations and Potential Driver Genes.

Authors:  Susannah La-Touche; Christophe Lemetre; Maryou Lambros; Elzbieta Stankiewicz; Charlotte K Y Ng; Britta Weigelt; Ramzi Rajab; Brendan Tinwell; Cathy Corbishley; Nick Watkin; Dan Berney; Jorge S Reis-Filho
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.